Condition: Aortic Valve Stenosis · Sponsor: Meril Life Sciences Pvt. Ltd.
A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting.
This description comes directly from the study's public registry record.
Ashok Thakkar, Ph.D. · +91-260-3063880 · Ashok.Thakkar@merillife.com
Always discuss trial participation with your own doctor first.
| North Estonia Medical center | Tallinn, Estonia | Recruiting |
| Clinical Institute Saint Ambrogio | Milan, Italy | Recruiting |
| Amphia Ziekenhui | Breda, North Brabant, Netherlands | Recruiting |
| University of Gdansk | Gdansk, Bażyńskiego, Poland | Recruiting |
| University Medical Centre Ljubljana | Ljubljana, Slovenia | Recruiting |
| Hospital Universitario de Gran Canaria Dr. Negrin | Las Palmas de Gran Canaria, Spain | Recruiting |
| Hospital Cliinico Univertistario de Valladolid | Valladolid, Spain | Recruiting |
| Kocaeli University School of Medicine | Kocaeli, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04703699